|
|
|
Jon O'Connell with Sarah Hein, Ph.D., March Biosciences | Fratricide is one of the key reasons T-cell therapies targeting T-cell malignancies have faltered. March's approach aims to solve that with its MB-105 candidate. | |
|
|
| Preventing Gas Ingress In Single-Layer Fluoropolymer Bags | Article | By Joe Cintavey, W.L. Gore & Associates | While barrier films in bags can be useful for cold chain applications, they do not fully protect against gas ingress and ignore other sources of permeability. See how these issues can be addressed. |
|
|
|
| Developing Community-Based And Trial-Naïve Sites: The Real ROI | Article | By Catherine Jervis, MRN - Medical Research Network | Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment. |
|
|
|
|
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
| Connect With Cell & Gene: |
|
|
|